A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments

Vaccine

Volumn 18, Issue 19, 2000, Pages 1975-1981

  Mars, M H ^a   De Jong, M C M ^b   Van Oirschot, J T ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Pathobiology Epidemiol   (Netherlands)

Author keywords

BHV1; Reactivation; Transmission

Indexed keywords

BAYOVAC IBR MARKER VIRUM; CORTICOSTEROID; DEXAMETHASONE; LIVE VACCINE; PREDNISOLONE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BOVINE HERPES VIRUS; CATTLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS MUTANT; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; DEXAMETHASONE; GLUCOCORTICOIDS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; PREDNISOLONE; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRUS ACTIVATION;

EID: 0033998346     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00536-8     Document Type: Article

References (31)

1. Kaashoek M.J., Moerman A., Madić J., et al. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine. 12:1994;439-444.
2. Strube W., Auer S., Block W., et al. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. Veterinary Microbiology. 53:1996;181-189.
3. Bosch J.C., Kaashoek M.J., Kroese A.H., Van Oirschot J.T. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Veterinary Microbiology. 52:1996;223-234.
4. Bosch J.C., Kaashoek M.J., Van Oirschot J.T. Inactivated bovine herpesvirus 1 (BHV1) marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine. 15:(14):1997;1512-1517.
5. Bosch JC, De Jong MCM, Van Bree J, Van Oirschot JT. Quantification of transmission of bovine herpesvirus 1 in cattle vaccinated with marker vaccines. In: PhD thesis Bosch JC. Bovine herpesvirus 1 marker vaccines: tools for eradication? Utrecht University, 1997, pp. 54-65.
6. Van Engelenburg FAC, Kaashoek MJ, Van Oirschot JT, Rijsewijk FAM. A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period. Journal of General Virology 1995; 76: 2387-92. 341-348.
7. Rock D.L. Latent infection with bovine herpesvirus type 1. Seminars in Virology. 5:1994;233-240.
8. Sheffy B.E., Davies D.H. Reactivation of a bovine herpesvirus after corticosteroid treatment. The Proceedings of the Society for Experimental Biology and Medicine. 140:1972;974-976.
9. Pastoret P.-P., Babiuk L.A., Misra V., Griebel P. Reactivation of temperature-sensitive and non temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone. Infection and Immunity. 29:(2):1980;483-488.
10. Kaashoek M.J., Straver P.H., Van Rooy E.M.A., Quak J., Van Oirschot J.T. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects. The Veterinary Record. 139:1996;416-421.
11. Thiry E., Saliki J., Bublot M., Pastoret P.-P. Reactivation of infectious bovine rhinotracheitis virus by transport. Comparative Immunology Microbiology and Infectious Diseases. 10:(1):1987;59-63.
12. Whetstone C.A., Miller J.M., Seal B.S., Bello L.J., Lawrence W.C. Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Archives of Virology. 122:1992;207-214.
13. Wentzel E. Untersuchungen zur Latenz und Reaktivierung einer natürlichen BHV1-Mutante mit einer gE-Deletion. Inaugural Dissertation Universität München, 1996.
14. Hage J.J., Schukken Y.H., Barkema H.W., Benedictus G., Rijsewijk F.A.M., Wentink G.H. Population dynamics of bovine herpesvirus 1 infection in a dairy herd. Veterinary Microbiology. 54:1996;169-180.
15. De Jong M.C.M., Kimman T.G. Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine. 12:(8):1994;761-766.
16. Kramps J.A., Magdalena J., Quak S., Weerdmeester K., Kaashoek M.J., Maris-Veldhuis M.A., Rijsewijk F.A.M., Keil G., Van Oirschot J.T. A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1. Journal of Clinical Microbiology. 32:1994;2175-2181.
17. Madić J., Magdalena J., Quak J., Van Oirschot J.T. Isotype-specific antibody responses to bovine herpesvirus 1 in sera and mucosal secretions of calves after experimental re-infection and after reactivation. Veterinary Immunology and Immunopathology. 47:1995;81-92.
18. De Wit J.J., Hage J.J., Brinkhof J., Westenbrink F. A comparative study of serological tests for use in the bovine herpesvirus 1 eradication program in the Netherlands. Veterinary Microbiology. 61:1998;153-163.
19. Wellenberg G.J., Verstraten E.R.A.M., Mars M.H., Van Oirschot J.T. Detection of bovine herpesvirus 1 glycoprotein E antibodies in individual milk samples by enzyme linked immunosorbent assays. Journal of Clinical Microbiology. 36:1998;409-413.
20. Bouma A., De Jong M.C.M., Kimman T.G. The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination. Vaccine. 15:1997;287-294.
21. Schang L.M., Osorio F.A. Quantitation of latency established by attenuated strains of Pseudorabies (Aujeszky's disease) virus. Journal of Virological Methods. 50:1994;269-280.
22. Rebordosa X., Piñol J., Pérez-Bons J.A., et al. Glycoprotein E of bovine herpesvirus type 1 is involved in virus transmission by direct cell-to-cell spread. Virus Research. 45:1996;59-68.
23. Bratanich A.C., Jones C.J. Localization of cis-acting sequences in the latency-related promoter of bovine herpesvirus 1 which are regulated by neuronal cell type factors and immediate-early genes. Journal of Virology. 66:(10):1992;6099-6106.
24. Tal-Singer R., Podrzucki W., Lasner T.M., et al. Use of differential display reverse transcription-PCR to reveal cellular changes during stimuli that result in herpes simplex virus type 1 reactivation from latency: upregulation of immediate-early cellular response genes TIS7, interferon, and interferon regulatory factor-1. Journal of Virology. 72:(2):1998;1252-1261.
25. Kennedy P.G.E., Steiner I. A molecular and cellular model to explain the differences in reactivation from latency by herpes simplex and varicella-zoster viruses. Neuropathology and Applied Neurobiology. 20:1994;368-374.
26. Maggioncalda J., Mehta A., Hsiu Su Y., Fraser M.B., Block T.N. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology. 225:1996;72-81.
27. Card J.P., Whealy M.E., Robbins A.K., Enquist L.B. Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system. Journal of Virology. 66:(5):1992;3032-3041.
28. Dingwell K.S., Doring L.C., Johnson D.C. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. Journal of Virology. 69:(11):1995;7087-7098.
29. Denis M., Splitter G., Thiry E., Pastoret P.-P., Babiuk L.A. Infectious bovine rhinotracheitis (bovine herpesvirus 1): helper T cells, cytotoxic T cells, and NK cells. Goddeeris B.N.L., Morrison W.I. Cell-mediated immunity in ruminants. 1994;157-172 CRC Press, New York.
30. Posavad C.M., Koelle D.M., Corey L. Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nature Medicine. 4:(4):1998;381-382.
31. Mars MH, de Jong MCM, van Oirschot JT. A gE negative BHV1 vaccine virus strain cannot perpetuate in cattle populations. Vaccine. Accepted for publication.